SCHRODER INVESTMENT MANAGEMENT GROUP - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$2,348,000
+20.0%
98,432
+3.6%
0.00%0.0%
Q1 2021$1,956,000
-55.9%
95,009
-47.6%
0.00%0.0%
Q4 2020$4,438,000
+38.9%
181,144
+57.1%
0.00%
-40.0%
Q3 2020$3,194,000
+527.5%
115,333
+7.8%
0.01%
+400.0%
Q2 2020$509,000
+73.1%
107,030
+20.7%
0.00%0.0%
Q1 2020$294,000
-3.9%
88,6540.0%0.00%
Q4 2019$306,000
-12.1%
88,6540.0%0.00%
-100.0%
Q3 2019$348,000
+22.1%
88,6540.0%0.00%0.0%
Q2 2019$285,000
-77.9%
88,654
-52.7%
0.00%
-50.0%
Q1 2019$1,288,000
+96.6%
187,458
+29.4%
0.00%
+100.0%
Q4 2018$655,000
-36.2%
144,874
+7.2%
0.00%
-50.0%
Q3 2018$1,026,000
-17.5%
135,1660.0%0.00%0.0%
Q2 2018$1,244,000
+157.0%
135,166
+104.9%
0.00%
+100.0%
Q1 2018$484,000
-27.7%
65,9610.0%0.00%0.0%
Q4 2017$669,000
-38.5%
65,9610.0%0.00%
-50.0%
Q3 2017$1,088,00065,9610.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 14,378,802$342,935,0004.38%
SILVERARC CAPITAL MANAGEMENT, LLC 122,700$2,926,0001.30%
COMMODORE CAPITAL LP 145,453$3,469,0001.21%
Asymmetry Capital Management, L.P. 63,259$1,509,0001.04%
Opaleye Management Inc. 250,000$5,963,0000.99%
Ikarian Capital, LLC 500,000$11,924,0000.96%
HighVista Strategies LLC 44,750$1,068,0000.76%
SILVERARC CAPITAL MANAGEMENT, LLC 63,915$1,524,0000.68%
Altium Capital Management LP 104,626$2,495,0000.58%
Integral Health Asset Management, LLC 75,000$1,789,0000.49%
View complete list of SERES THERAPEUTICS INC shareholders